TrialCancer2023

Entospletinib with decitabine in acute myeloid leukemia with mutant TP53 or complex karyotype: A phase 2 substudy of the Beat AML Master Trial.

Vu H Duong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.